Threshold Reports Positive Phase II Results For Glufosfamide For Advanced Pancreatic Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Company is exploring next steps for the oncologic in the pancreatic cancer setting while trials are ongoing for other cancers.